J&J inks collab deal to develop MERS vaccine

J&J inks collab deal to develop MERS vaccine

Source: 
Drug Delivery Business News
News Tags: 
snippet: 

Healthcare giant Johnson & Johnson (NYSE:JNJ) today announced a new collaborative deal as it looks to develop a vaccine against Middle East Respiratory Syndrome Coronavirus.